期刊文献+

间充质干细胞条件培养基对炎症介导的肺动脉血管平滑肌细胞增殖调控的研究 被引量:2

Regulation of Mesenchymal Stem Cell Conditioned Medium on Proliferation of Pulmonary Artery Smooth Muscle Cells Mediated by Inflammation
下载PDF
导出
摘要 目的:探讨间充质干细胞条件培养基(MSC-CM)对炎症介导的肺动脉血管平滑肌细胞(PASMC)增殖的调控机制。方法:取4~6代处于对数生长期人脐带MSC,建立体外细胞培养体系,分为对照组(PASMC)、T淋巴细胞刺激组(PASMC+T淋巴细胞)、MSC-CM干预组(PMSMC+T淋巴细胞+MSC-CM);分别于培养第3天时,检测3组培养上清中肿瘤坏死因子(TNF)-α含量、PASMC的增殖、钙调神经磷酸酶(Ca N)活性及活化的T淋巴细胞核因子2(NFATc2)活化情况。结果:与T淋巴细胞刺激组比较,MSC-CM干预组TNF-α的生成显著减少(P<0.01);与对照组和T淋巴细胞刺激组比较,MSC-CM干预组的PASMC内Ca N的磷酸酶活性降低、NFATc2的活化减少,PASMC的增殖降低(P<0.01)。结论:MSC-CM可能通过Ca N/NFAT信号通路抑制炎症介导的PASMC增殖。 Objective: To investigate the regulatory mechanism of Mesenchymal Stem Cell conditioned medium( MSC-CM) on proliferation of pulmonary artery smooth muscle cells( PASMC) mediated by inflammation. Methods: In vitro cell culture system was established by taking MSC from human umbilical cord at logarithmic growth stage and divided into control group( PASMC),T lymphocyte stimulation group( PASMC + T lymphocyte) and MSC-CM intervention group( PASMC + T lymphocyte+ MSC-CM). On the third day of culture,the levels of tumor necrosis factor( TNF)-α in culture supernatant,proliferation of PASMC,Ca N activity and activated NFATc2 were assessed. Results: The production of TNF-α in MSC-CM intervention group was significantly lower than that in T-lymphocyte stimulation group( P〈0. 01). Compared with control group and T lymphocyte stimulation group,the activity of Ca N phosphatase in PASMC of MSC-CM intervention group was decreased,activation of NFATc2 was reduced,and the proliferation of PASMC was reduced( P〈0. 01). Conclusion: MSCCM inhibits the proliferation of PASMC mediated by inflammation through the Ca N/NFAT signaling pathway.
作者 牛志浩 刘庆 刘俊峰 吴西军 何志旭 NIU Zhihao;LIU Qing;LIU Junfeng;WU Xijun;HE Zhixu(Clinical Laboratory,North China Petroleum General Administration Hospital,Renqiu 062552,Hebei,China;Department of Respiratory and Critical Care Medicine,Affiliated Hospital of Guizhou Medical University,Gu,iyang 550004,Guizhou,China;Tissue Engineering and Stern Cell Researeh Center,Guizhou Medical University,Guiyang 550004,Guizhou,China;Department of immunology,Guizhou Medical University,Guiyang 550004,Guizhou,China;Department of Child Blood Oncology,Affiliated Hosptial of Guizhou Medical University,Guiyang 550004,Guizhou,China)
出处 《贵州医科大学学报》 CAS 2018年第6期641-645,共5页 Journal of Guizhou Medical University
基金 国家自然科学基金项目(30560159) 贵州省"125计划"重大科技专项[黔教合重大专项字(2013)021] 贵阳市-贵州医科大学联合科技计划项目[筑科合同(20151001)03]
关键词 间充质干细胞 肺动脉高压 平滑肌 增殖 肿瘤坏死因子-Α T淋巴细胞核因子2 钙调神经磷酸酶 mesenchymal stem cell pulmonary arterial hypertension smooth muscle proliferation tumor necrosis factor-α nuclear factor of activated T-cells calcineurin
  • 相关文献

参考文献3

二级参考文献19

  • 1LIU J F,DU Z D,CHEN Z,et al.Granulocyte colony-stimulating factor attenuates monocrotaline-induced pulmonary hypertension by upregulating endothelial progenitor cells via the nitric oxide system[J].Exp Ther Med,2013,6(6):1402-1408.
  • 2BAZAN I S,FARES W H.Pulmonary hypertension:diagnostic and therapeutic challenges[J].Ther Clin Risk Manag,2015,11;1221-1233.
  • 3LOW A T,MEDFORD A,MILLAR A B,et al.Lung function in pulmonary hypertension[J].Respir Med,2015,109(10):1244-1249.
  • 4KRISHNAN U,ROSENZWEIG E B.Pulmonary hypertension in chronic lung disease of infancy[J].Curr Opin Pediatr,2015,27(2):177-183.
  • 5PUGLIESE S C,POTH J M,F1N1 M A,et al.The role of inflammation in hypoxic pulmonary hypertension;from cellular mechanisms to clinical phenotypes[J].Am J Physiol Lung Cell Mol Physiol,2015,308(3):L229-L252.
  • 6COHEN-KAMINSKY S,HAUTEFORT A,PRICE L,et al.Inflammation in pulmonary hypertension:what we know and what we could logically and safely target first[J].Drug Discov Today,2014,19(8):1251-1256.
  • 7BONNET S,ROCHEFORT G,SUTENDRA G,et al.The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted[J].Proc Natl Acad Sci U S A,2007,104(27):11418-11423.
  • 8PULLAMSETTI S S,SAVAI R,JANSSEN W,et al.Inflammation,immunological reaction and role of infection in pulmonary hypertension[J].Clin Microbiol Infect,2011,17(1):7-14.
  • 9VISWESWARAN M,POHL S,ARFUSO F,et al.Multi-lineage differentiation of mesenchymal stem cells-To Wnt,or not Wnt[J].Int J Biochem Cell Biol,2015,68:139-147.doi:10.1016/j.biocel.2015.09.008.
  • 10WYLES C C,HOUDEK M T,BEHFAR A,et al.Mesenchymal stem cell therapy for osteoarthritis:current perspectives[J].Stem Cells Cloning,2015,8:117-124.

共引文献11

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部